SCHEMBL27445582

SCHEMBL27445582

CC(C)c1ccc2c(c1)C1(CC1)CN(C)C2=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 2/20 0.41
SIGMAR1 Q99720 1/20 0.41
HPGD P15428 1/20 0.38
GFER P55789 1/20 0.38
HSD17B10 Q99714 1/20 0.38
NR1H3 Q13133 1/20 0.36
LMNA P02545 2/20 0.36
OPRK1 P41145 2/20 0.36
OPRL1 P41146 1/20 0.36
PDK2 Q15119 1/20 0.35
TSHR P16473 1/20 0.34
ALDH1A1 P00352 2/20 0.33
OPRD1 P41143 2/20 0.33
CYP3A4 P08684 1/20 0.33
MAPT P10636 1/20 0.33
ALOX15 P16050 1/20 0.33
OTUD7B Q6GQQ9 1/20 0.33
NOTUM Q6P988 1/20 0.33
RNASEH1 O60930 1/20 0.33
MAOA P21397 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27445638 0.94 OPRM1 (0.40) OPRM1SIGMAR1HPGDGFERHSD17B10
SCHEMBL20883903 0.88 HPGD (0.41) OPRM1SIGMAR1HPGDGFERHSD17B10
SCHEMBL25452842 0.80 OPRM1 (0.44) OPRM1SIGMAR1LMNATSHRALDH1A1
SCHEMBL27445311 0.75 HPGD (0.40) OPRM1HPGDGFERHSD17B10NR1H3
SCHEMBL27445652 0.74 HTR2A (0.30)
SCHEMBL26849180 0.73 HPGD (0.44) OPRM1HPGDGFERHSD17B10NR1H3
SCHEMBL24525769 0.73 MEN1 (0.44) OPRM1SIGMAR1NLRP3MEN1KMT2A
SCHEMBL13637297 0.72 GRM5 (0.54) HPGDGFERHSD17B10NR1H3LMNA
SCHEMBL19368987 0.72 MEN1 (0.50) HPGDGFERHSD17B10OPRD1MEN1
SCHEMBL12545696 0.71 NPSR1 (0.41) HPGDGFERHSD17B10NR1H3LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024119122-A1 CDK INHIBITORS AND METHODS AND USE THEREOF RELAY THERAPEUTICS, INC. (US) 2024-06-06 WO disclosed